Treatment of Staphylococcus aureus catheter-related infection and infective endocarditis with granulocyte colony-stimulating factor in the experimental rabbit model

Antimicrob Agents Chemother. 1996 May;40(5):1308-10. doi: 10.1128/AAC.40.5.1308.

Abstract

The role of granulocyte colony-stimulating factor with and without antibiotics in the treatment of catheter-related infection and infective endocarditis caused by methicillin-susceptible Staphylococcus aureus was assessed in the experimental rabbit model. Granulocyte colony-stimulating factor stimulated leukocytosis in infected animals but did not increase the clearance of methicillin-susceptible S. aureus from peripheral blood, subcutaneous port catheters, intravascular cardiac catheters, or aortic valve vegetations.

MeSH terms

  • Animals
  • Cardiac Catheterization
  • Ceftriaxone / administration & dosage
  • Ceftriaxone / therapeutic use*
  • Cephalosporins / administration & dosage
  • Cephalosporins / therapeutic use*
  • Drug Combinations
  • Endocarditis, Bacterial / drug therapy*
  • Endocarditis, Bacterial / microbiology
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Leukocyte Count / drug effects
  • Rabbits
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects*
  • Survival Analysis

Substances

  • Cephalosporins
  • Drug Combinations
  • Granulocyte Colony-Stimulating Factor
  • Ceftriaxone